Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.
Not all reports are available for public preview. For more information, please contact us.
Botaretigene sparoparvovec is an investigational gene replacement therapy for the treatment of X-linked retinitis pigmentosa due to mutations in the RPGR gene. It is administered by subretinal injection.
Donanemab is an investigational, intravenously administered amyloid beta-directed antibody proposed for the treatment of Alzheimer disease.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of laser interstitial thermal therapy (LITT), also known as stereotactic laser ablation (SLA), for the treatment of brain radiation necrosis (RN).
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of EndeavorRx (Akili Interactive Labs Inc.) to improve attention function in children with attention-deficit/hyperactivity disorder (ADHD).
This report evaluates the clinical validity and clinical utility of the Signatera test.
Amvuttra (vutrisiran) is an injectable RNA interference (RNAi) therapeutic agent indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the leva Pelvic Health System (Renovia Inc.) for the treatment of urinary incontinence (UI) in female patients.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of VivAer (Aerin Medical Inc.) for the treatment of nasal airway obstruction (NAO).
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of laser interstitial thermal therapy (LITT), also known as stereotactic laser ablation (SLA), for the treatment of recurrent metastatic brain neoplasms.
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the effectiveness and safety of theta burst stimulation (TBS), alone and compared with repetitive transcranial magnetic stimulation (rTMS) and/or with sham TBS, for the management of treatment-resistant major depressive disorder (MDD) (unipolar treatment-…